MedPath

Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)

Phase 2
Completed
Conditions
Pulmonary Arterial Hypertension
Interventions
Drug: placebo
Registration Number
NCT01553721
Lead Sponsor
Dong-A ST Co., Ltd.
Brief Summary

This is a placebo-controlled, double-blind, phase II clinical study to evaluate the efficacy and safety of Udenafil in patient with Pulmonary Arterial Hypertension(PAH).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
63
Inclusion Criteria

• Subjects aged 18 and over who have any of the following diseases

  • primary Pulmonary Arterial Hypertension
  • secondary Pulmonary Arterial Hypertension caused by connective tissue disease
  • [Phase IIb] Pulmonary Arterial Hypertension caused by congenital heart disease(including Eisenmenger syndrome)
Exclusion Criteria
  • Subjects with pulmonary arterial hypertension caused by any etiology other than those specified in the inclusion criteria
  • BMI(Body Mass Index) < 18.5kg/m2
  • Subjects with hypotension(SBP/DBP<90/50mmHg) or uncontrolled hypertension(SBP/DBP>170/100mmHg)
  • Creatinine clearance ≤ 30mL/min
  • History of non-arteritic anterior ischemic optic neuropathy(NAION)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
placeboplacebo1. Phase IIa Placebo Comparator : Placebo 2. Phase IIb Placebo Comparator : Placebo
udenafiludenafil1. Phase IIa Experimental : Udenafil Dose 1, Dose 2 2. Phase IIb Experimental : Udenafil
Primary Outcome Measures
NameTimeMethod
Phase IIb - 6-minute walk distance16weeks
Phase IIa - Pulmonary vascular resistance index(PVRI)4 hours
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (9)

Pusan national University Hospital

🇰🇷

Pusan, Korea, Republic of

Chonnam National University Hospital

🇰🇷

Gwang-ju, Korea, Republic of

Seoul National University Hospital

🇰🇷

Seoul, Chongno-gu, 28 Yongon-dong, Korea, Republic of

Samsung Medical Center

🇰🇷

Seoul, Gangnam-Gu, Irwon-Dong 50, Korea, Republic of

Severance Hospital, Yonsei University Health System

🇰🇷

Special City of Seoul, Seodaemungu, 250 Seonsanno, Korea, Republic of

Chungbook national University Hospital

🇰🇷

Chung-ju, Korea, Republic of

Chungnam National University Hospital

🇰🇷

Daejeon, Korea, Republic of

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

The catholic univ. of korea Seoul ST. MARY's hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath